Log on / register
Feedback | Support | My details
Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats.
Xu L, Fagan SC, Waller JL, Edwards D, Borlongan CV, Zheng J, Hill WD, Feuerstein G, Hess DC
BMC Neurol 2004 Apr 26, 4:7
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke
Matsukawa N, Yasuhara T, Hara K, Xu L, Maki M, Yu G, Kaneko Y, Ojika K, Hess DC, Borlongan CV
BMC Neuroscience 2009, 10:126 (6 October 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research article    
Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease
Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B
BMC Neuroscience 2009, 10:109 (1 September 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
3.


Research article    
Selection of reference genes for quantitative real-time PCR in a rat asphyxial cardiac arrest model
Langnaese K, John R, Schweizer H, Ebmeyer U, Keilhoff G
BMC Molecular Biology 2008, 9:53 (28 May 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
4.


Research article    
Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke
Machado LS, Kozak A, Ergul A, Hess DC, Borlongan CV, Fagan SC
BMC Neuroscience 2006, 7:56 (17 July 2006)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 2 articles in PubMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.